Cover Image
市場調查報告書

Biolab Sanus Farmaceutica Ltda. :產品平台分析

Biolab Sanus Farmaceutica Ltda. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 321957
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Biolab Sanus Farmaceutica Ltda. :產品平台分析 Biolab Sanus Farmaceutica Ltda. - Product Pipeline Review - 2014
出版日期: 2014年12月31日 內容資訊: 英文 24 Pages
簡介

Biolab Sanus Farmaceutica Ltda. 是開發、製造、商品化,以及輸出處方藥的製藥公司。該公司經手的疾病範圍有心臟系、皮膚科、內分泌系、婦產科系、小兒科、消化器官系統、整形外科、風濕等,同時也製造營養補充品。

本報告提供Biolab Sanus Farmaceutica Ltda.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,同時也提供最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Biolab Sanus Farmaceutica Ltda.的基本資料

Biolab Sanus Farmaceutica Ltda.概要

  • 主要資訊
  • 企業資料

Biolab Sanus Farmaceutica Ltda.:R&D概要

  • 主要的治療範圍

Biolab Sanus Farmaceutica Ltda.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Biolab Sanus Farmaceutica Ltda.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Biolab Sanus Farmaceutica Ltda.:藥物簡介

  • BL-123
  • BL-125
  • PB-5109
  • BL-122
  • BL-214
  • BL-249

Biolab Sanus Farmaceutica Ltda.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Biolab Sanus Farmaceutica Ltda.:總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC06777CDB

Summary

Global Markets Direct's, 'Biolab Sanus Farmaceutica Ltda. - Product Pipeline Review - 2014', provides an overview of the Biolab Sanus Farmaceutica Ltda.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Biolab Sanus Farmaceutica Ltda.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Biolab Sanus Farmaceutica Ltda. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Biolab Sanus Farmaceutica Ltda.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Biolab Sanus Farmaceutica Ltda.'s pipeline products

Reasons to buy

  • Evaluate Biolab Sanus Farmaceutica Ltda.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Biolab Sanus Farmaceutica Ltda. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Biolab Sanus Farmaceutica Ltda.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Biolab Sanus Farmaceutica Ltda. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Biolab Sanus Farmaceutica Ltda.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Biolab Sanus Farmaceutica Ltda. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Biolab Sanus Farmaceutica Ltda. Snapshot
    • Biolab Sanus Farmaceutica Ltda. Overview
    • Key Information
    • Key Facts
  • Biolab Sanus Farmaceutica Ltda.- Research and Development Overview
    • Key Therapeutic Areas
  • Biolab Sanus Farmaceutica Ltda.- Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products- Monotherapy
  • Biolab Sanus Farmaceutica Ltda.- Pipeline Products Glance
    • Biolab Sanus Farmaceutica Ltda.- Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Biolab Sanus Farmaceutica Ltda.- Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Biolab Sanus Farmaceutica Ltda.- Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Biolab Sanus Farmaceutica Ltda.- Drug Profiles
    • BL-123
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-125
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PB-5109
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-122
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-214
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-249
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Biolab Sanus Farmaceutica Ltda.- Pipeline Analysis
    • Biolab Sanus Farmaceutica Ltda.- Pipeline Products by Target
    • Biolab Sanus Farmaceutica Ltda.- Pipeline Products by Route of Administration
    • Biolab Sanus Farmaceutica Ltda.- Pipeline Products by Molecule Type
    • Biolab Sanus Farmaceutica Ltda.- Pipeline Products by Mechanism of Action
  • Biolab Sanus Farmaceutica Ltda.- Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Biolab Sanus Farmaceutica Ltda., Key Information
  • Biolab Sanus Farmaceutica Ltda., Key Facts
  • Biolab Sanus Farmaceutica Ltda.- Pipeline by Indication, 2014
  • Biolab Sanus Farmaceutica Ltda.- Pipeline by Stage of Development, 2014
  • Biolab Sanus Farmaceutica Ltda.- Monotherapy Products in Pipeline, 2014
  • Biolab Sanus Farmaceutica Ltda.- Phase III, 2014
  • Biolab Sanus Farmaceutica Ltda.- Phase I, 2014
  • Biolab Sanus Farmaceutica Ltda.- Preclinical, 2014
  • Biolab Sanus Farmaceutica Ltda. -Pipeline by Target, 2014
  • Biolab Sanus Farmaceutica Ltda.- Pipeline by Route of Administration, 2014
  • Biolab Sanus Farmaceutica Ltda.- Pipeline by Molecule Type, 2014
  • Biolab Sanus Farmaceutica Ltda.- Pipeline Products by Mechanism of Action, 2014
  • Biolab Sanus Farmaceutica Ltda., Other Locations

List of Figures

  • Biolab Sanus Farmaceutica Ltda. - Pipeline by Top 10 Indication, 2014
  • Biolab Sanus Farmaceutica Ltda. - Pipeline by Stage of Development, 2014
  • Biolab Sanus Farmaceutica Ltda. - Monotherapy Products in Pipeline, 2014
  • Biolab Sanus Farmaceutica Ltda. - Pipeline by Top 10 Molecule Type, 2014
Back to Top